Treatment of l1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-β-D-arabinofuranosyl cytosine
- 28 May 1992
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 51 (3), 466-469
- https://doi.org/10.1002/ijc.2910510321
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-β-d-arabinofuranosylcytosineEuropean Journal of Cancer and Clinical Oncology, 1984
- Treatment of Acute Leukemia–Advances in Chemotherapy, Immunotherapy, and Bone Marrow TransplantationAdvances in Cancer Research, 1983
- Lipophilic 5'-alkyl phosphate esters of 1-.beta.-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugsJournal of Medicinal Chemistry, 1982
- 4-(1,2,4-Triazol-1-yl)- and 4-(3-nitro-1,2,4-triazol-1-yl)-1-(β-D-2,3,5-tri-O-acetylarabinofuranosyl)pyrimidin-2(1H)-ones. Valuable intermediates in the synthesis of derivatives of 1-(β-D-arabinofuranosyl)cytosine (ara-C)Journal of the Chemical Society, Perkin Transactions 1, 1982
- Effect and Mode of Action of N4-Behenoyl-β-D-ArabinofuranosylcytosineRecent Results in Cancer Research, 1980
- The synthesis of new derivatives of 1-.BETA.-D-arabinofuranosylcytosine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1978
- Enhancement of anti-tumor activity of 1-β-d-arabinofuranosylcytosine by encapsulation in liposomesInternational Journal of Cancer, 1977
- Pharmacokinetics of cytosine arabinoside in acute myeloid leukemiaClinical Pharmacology & Therapeutics, 1977
- Pyrimidine nucleosides. 6. Synthesis and anticancer activities of N4-substituted 2,2'-anhydronucleosidesJournal of Medicinal Chemistry, 1974
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971